CICC Jiacheng Investment Management
VC Fund
Beijing, China
CICC Jiacheng Investment Management is an Investment firm.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries CICC Jiacheng Investment Management invests in
ManufacturingHealth CareBiotechnologyMedicalSoftware
Stages CICC Jiacheng Investment Management invests in
Series CSeries DSeries B
Countries CICC Jiacheng Investment Management invests in
China
Investment Focus
Industry
- Manufacturing 4 (40%)
- Health Care 3 (30%)
- Biotechnology 3 (30%)
- Medical 2 (20%)
- Software 2 (20%)
Stage
- Series C 4 (40%)
- Series D 4 (40%)
- Series B 2 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Advanced Materials Technology & Engineering
|
Advanced Materials Tech& Eng is a semiconductor equipment manufacturer that focuses on the development of front-end process equipment, compound semiconductors and MEMS. | $70.4M / Series D / Jan 29, 2024 | |
Yingsheng Biology
|
Yingsheng Biotechnology Co., Ltd. (referred to as Yingsheng Bio) was established in 2009, and is committed to the application of molecular diagnostic techniques such as maternal and child health, neonatal genetic diseases, metabolic diseases, birth defects and other human genetics, and national eugenics engineering. Yingsheng's product lineincludes 45 innovative genetic metabolic disease screening reagents, 14 vitamins determination reagents, mass spectrometer automatic intelligent processing platform, and ultra-high performance liquid chromatography tandem mass spectrometry detection system. level. | Series C / Mar 29, 2022 | |
Creech Medical Technology Development
|
Creativity (Beijing) Medical Technology Development Co., Ltd. is a leading minimally invasive interventional delivery system product full solution provider. Committed to cooperating with top experts at home and abroad in the field of minimally invasive intervention, and cooperating with internationally renowned raw material manufacturers to jointlydevelop, produce and sell leading products. Provide doctors with differentiated diagnosis and treatment tools, relieve patients' pain and reduce medical burden. | Series D / Dec 22, 2021 | |
Horizon Robotics
|
Horizon Robotics is a leading provider of ADAS and AD solutions for passenger vehicles with proprietary software and hardware. Our solutions combine cutting-edge algorithms, purpose-built software and state-of-the-art processing hardware, providing the core technologies for assisted and autonomous driving that enhance the safety and experience ofdrivers and passengers. | $600M / Series C / Jun 10, 2021 | |
WT Microtech Medical
|
WT Microtech Medical mainly engaged in the R&D, production, sales and maintenance of the third category of medical devices. | $81.5M / Series D / Dec 28, 2020 | |
Microtech Medical
|
MicroTech Medical founded in January, 2011 in Hangzhou Future Technical City, which is the Industrial Garden for High-level Overseas Talents in Zhejiang Province, recieved capital from Eli Lilly and Company. They devote to innovate and manufacture high-tech and more affordable medical devices related to Diabetes Care. | $88M / Series D / Dec 28, 2020 | |
Paraview Software
|
Paraview Software is an enterprise-level IT management platform solution provider with ParaSecure OSC operation and maintenance security management software and ParaSecure AAC security log management system software. | $44.1M / Series C / Sep 23, 2020 | |
Thousand Oaks Biopharmaceuticals
|
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providingbio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services. | Series B / Jul 24, 2020 | |
Yihang.ai
|
Yihang.ai manufactures autonomous driving systems. Yihang Intelligent provides the host factory with a complete auto-driving solution with high reliability, high quality and low cost. Since its establishment, Yihang Intelligent has been aiming at productization and strictly follows the development process of the main engine factory. At present,Autopilot has been commercialized, and Autopilot function autopilot solution is provided for a certain production model. It is applied to Level 4 deep learning technology research and development. Breakthroughs have also been made to achieve real-time pixel-level image segmentation based on deep learning on a car-level embedded chip. Yihang intelligent team is proficient in artificial intelligence and core algorithms such as sensing, decision-making, control and fault diagnosis. It integrates the elites of the automotive industry and experts in computer vision and deep learning. The team members are from domestic and foreign OEMs, Tier 1 suppliers, domestic and foreign. Leading scientific research institutions and famous universities at home and abroad such as Berkeley and Cambridge.It began operation in 2015, with its headquarters in Beijing in China. | $31.2M / Series B / Aug 29, 2018 | |
Unisound
|
Beijing Yunzhisheng Information Technology Co., Ltd. (云知声语音云) is a Chinese mobile internet startup focused on intelligent voice and speech processing technologies. Founded in June 2012, the company owns the speech recognition technologies with intellectually independent property rights. With the help of a cloud computing platform and mobileinternet technologies, it has launched a series of middleware and cloud platforms for speech recognition services, which provides internet enterprises and users with professional speech recognition services. Yunzhisheng’s core technology team is made up of people from domestically and internationally well-known enterprises, universities, and research institutes, of which above 80% own a doctoral degree along with more than 10 years of experience in the R&D of applications in voice recognition. | $85M / Series C / Jul 19, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Climate Investors
40,325 investors
Manufacturing Investors
24,696 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
SaaS VC Funds
61,208 investors
FAQ
What does CICC Jiacheng Investment Management invest in?
CICC Jiacheng Investment Management invests primarily in Manufacturing, Health Care and Biotechnology startups, most often at Series C and Series D stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did CICC Jiacheng Investment Management last invest?
The most recent investment recorded for CICC Jiacheng Investment Management closed in Jan 2024. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
